Ionis Pharmaceuticals (IONS) Change in Acquisitions & Divestments (2009 - 2026)

Ionis Pharmaceuticals' Change in Acquisitions & Divestments history runs 18 years deep, the most recent figure standing at $362.0 million for Q2 2026.

• In Q2 2026, Change in Acquisitions & Divestments fell 6.17% year-over-year to $362.0 million; the TTM figure through Jun 2026 stood at $1.9 billion (up 14.92% YoY), while the FY2025 annual figure was $1.7 billion, down 4.03% from the prior year.
• Change in Acquisitions & Divestments for Q2 2026 stood at $362.0 million, down from $752.8 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $752.8 million in Q1 2026, with the low at $178.8 million in Q1 2022.
• The 5-year median for Change in Acquisitions & Divestments is $384.8 million (2022), against an average of $397.5 million.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments sank 56.58% in 2022, then surged 109.33% in 2023.
• Ionis Pharmaceuticals' Change in Acquisitions & Divestments stood at $225.1 million in 2022, then surged by 73.72% to $391.0 million in 2023, then grew by 9.96% to $429.9 million in 2024, then decreased by 8.09% to $395.1 million in 2025, then fell by 8.39% to $362.0 million in 2026.
• Business Quant data shows IONS's Change in Acquisitions & Divestments at $362.0 million in Q2 2026, $752.8 million in Q1 2026, and $395.1 million in Q4 2025.